NetherlandsTuberculosis profile
Population  2014 17 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.022 (0.021–0.022) 0.13 (0.13–0.13)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.05)
Prevalence  (includes HIV+TB) 1.2 (0.52–2.2) 7.2 (3.1–13)
Incidence  (includes HIV+TB) 0.97 (0.85–1.1) 5.8 (5.1–6.5)
Incidence (HIV+TB only) 0.052 (0.043–0.061) 0.31 (0.26–0.36)
         
Case detection, all forms (%) 84 (74–95)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0.92 (0.19–2.7) 13 (0.32–53)
MDR-TB cases among notified pulmonary
TB cases
4 (1–12) 2 (0–8)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 354   5
Pulmonary, clinically diagnosed 87   1
Extrapulmonary 363   4
       
Total new and relapse 814    
Previously treated, excluding relapses 9    
Total cases notified 823    
Among 814 new and relapse cases:
48 (6%) cases aged under 15 years; male:female ratio: 1.6
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 463 (131%) 11 (58%) 519
Laboratory-confirmed RR-/MDR-TB cases     7
Patients started on MDR-TB treatment ***     6
TB/HIV 2014 Number (%)
TB patients with known HIV status 424 (52)
HIV-positive TB patients 23 (5)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (88) 816
Previously treated cases, excluding relapse, registered in 2013 (75) 12
HIV-positive TB cases, all types, registered in 2013 (76) 17
RR-/MDR-TB cases started on second-line treatment in 2012 (73) 11
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions) 37
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-05-02 Data: www.who.int/tb/data